Medical Condition News

RSS

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announce today the release of the initial results from the first-in-human study of its unique drug-coated balloon, Chocolate Heart.

7 Jan 2016

Elsevier's new open access journal features novel method to make cancer clinical trials more effective

The first issue of Elsevier's new open access journal Contemporary Clinical Trials Communications features a new method to make cancer clinical trials more effective, a better way of determining whether a trial was successful and a dashboard that helps patients enroll in trials.

7 Jan 2016

Does cancer affect memory? An interview with Associate Professor Janette Vardy

The study evaluated cognitive function in patients with colorectal cancer. It characterized the incidence and severity of cognitive impairment in people with colorectal cancer (CRC) compared to healthy controls.

7 Jan 2016

Critically ill patients exposed to higher ozone levels more likely to develop ARDS

Critically ill patients who are exposed to higher daily levels of ozone are more likely to develop acute respiratory disease syndrome (ARDS), according to a new study published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

7 Jan 2016

Penn study provides new insight into cause of peripartum cardiomyopathy in pregnant women

Each year approximately 1 in 1,000 pregnant women will experience peripartum cardiomyopathy, an uncommon form of often severe heart failure that occurs in the final month of pregnancy or up to five months following delivery. But the cause of peripartum cardiomyopathy has been largely unknown - until now.

7 Jan 2016

Jubilant Biosys, Sanofi partner to develop small molecule inhibitors in metabolic disorders therapeutic area

Jubilant Biosys Ltd, a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd, and Sanofi Deutschland GmbH, Frankfurt, Germany, announced a strategic alliance to discover and develop small molecule inhibitors for multiple targets in the metabolic disorders therapeutic area.

7 Jan 2016

Scientists discover molecular mechanism responsible for degeneration of Purkinje cells in SCA1

Scientists from Bern have discovered a mechanism which is responsible for the degeneration of Purkinje cells in the cerebellum in a neurodegenerative disease called Spinocerebellar ataxia type 1. The results of their study open up new avenues for the future treatment of cerebellum associated degenerative disorders.

7 Jan 2016

Transgender veterans have significantly greater prevalence of many psychiatric and medical conditions

The first large, controlled study of health disparities between clinically diagnosed transgender and non-transgender patients-based on the medical records of more than 5,000 patients treated in the Veterans Health Administration-showed that transgender veterans had a significantly greater prevalence of numerous psychiatric and medical conditions.

7 Jan 2016

ACP publishes new Strategy for improving cancer patient outcomes

The Association for Cancer Physicians, which represents and supports medical oncologists in the UK, has published a new Strategy for improving cancer patient services and outcomes.

7 Jan 2016

New injectable agent can potentially increase surgeon's ability to remove cancerous tumor during surgery

Doctors at the Duke University School of Medicine have tested a new injectable agent that causes cancer cells in a tumor to fluoresce, potentially increasing a surgeon's ability to locate and remove all of a cancerous tumor on the first attempt. The imaging technology was developed through collaboration with scientists at Duke, the Massachusetts Institute of Technology and Lumicell Inc.

7 Jan 2016

MU researcher exploring ways to meet the needs of young adults with autism

As the number of children diagnosed with autism spectrum disorders continues to rise, medical professionals have emphasized early diagnosis, intervention and treatment. However, less attention has been given to children with autism once they reach their teen years and adulthood.

7 Jan 2016

Rutgers offers two-year fellowship program to enhance training of cancer surgeons

Aiming to enhance the training of cancer surgeons, a two-year fellowship program is now being offered by Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School. The Fellowship in Complex General Surgical Oncology offers board-eligible surgeons an opportunity to subspecialize in the intricacies of cancer care both in the clinical and research arenas.

7 Jan 2016

Injectable microwheels can effectively treat arterial blockages

Biomedical microwheel research conducted by members of the Colorado School of Mines Department of Chemical and Biological Engineering has been published in Nature Communications.

7 Jan 2016

Palliative care improves care quality, reduces costs for advanced cancer patients with comorbidities

Patients with incurable cancer and numerous other serious health conditions who consulted with a palliative care team within two days of hospitalization had significant savings in hospital costs, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.

7 Jan 2016

Drexel biomedical engineer identifies immune cell as potential strategy for growing blood vessels

In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.

7 Jan 2016

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

7 Jan 2016

Scientists reveal underlying mechanisms that lead to more difficult-to-treat symptoms of schizophrenia

Scientists at Columbia University's Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University Medical Center, and the Université Paris Descartes have found that deficits in social memory--a crucial yet poorly understood feature of psychiatric disorders such as schizophrenia--may be due to a decrease in the number of a particular class of brain cells, called inhibitory neurons, in a little-explored region within the brain's memory center.

7 Jan 2016

Study shows that twins may share cancer risk

In a long-term follow-up study among approximately 200,000 Nordic twin individuals, there was an increased cancer risk in twins whose co-twin was diagnosed with cancer, with an increased risk for cancer overall and for specific types of cancer, including prostate, melanoma, breast, ovary, and uterus, according to a study in the January 5 issue of JAMA.

7 Jan 2016

People with low sunlight exposure and vitamin D deficiency at greater risk of developing leukemia

Epidemiologists at University of California, San Diego School of Medicine report that persons residing at higher latitudes, with lower sunlight/ultraviolet B (UVB) exposure and greater prevalence of vitamin D deficiency, are at least two times at greater risk of developing leukemia than equatorial populations.

7 Jan 2016

CUMC study reveals statins may help reduce heart disease risk in people with sleep apnea

A new study conducted at Columbia University Medical Center has revealed some of the underlying mechanisms that may increase the risk of heart disease in people with sleep apnea. The study also found that statins -- the cholesterol-lowering medications commonly prescribed to combat heart disease -- may help reverse this process.

7 Jan 2016

Medical Condition News

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

Elsevier's new open access journal features novel method to make cancer clinical trials more effective

Does cancer affect memory? An interview with Associate Professor Janette Vardy

Critically ill patients exposed to higher ozone levels more likely to develop ARDS

Penn study provides new insight into cause of peripartum cardiomyopathy in pregnant women

Jubilant Biosys, Sanofi partner to develop small molecule inhibitors in metabolic disorders therapeutic area

Scientists discover molecular mechanism responsible for degeneration of Purkinje cells in SCA1

Transgender veterans have significantly greater prevalence of many psychiatric and medical conditions

ACP publishes new Strategy for improving cancer patient outcomes

New injectable agent can potentially increase surgeon's ability to remove cancerous tumor during surgery

MU researcher exploring ways to meet the needs of young adults with autism

Rutgers offers two-year fellowship program to enhance training of cancer surgeons

Injectable microwheels can effectively treat arterial blockages

Palliative care improves care quality, reduces costs for advanced cancer patients with comorbidities

Drexel biomedical engineer identifies immune cell as potential strategy for growing blood vessels

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

Scientists reveal underlying mechanisms that lead to more difficult-to-treat symptoms of schizophrenia

Study shows that twins may share cancer risk

People with low sunlight exposure and vitamin D deficiency at greater risk of developing leukemia

CUMC study reveals statins may help reduce heart disease risk in people with sleep apnea

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News